Published in Cases J on October 20, 2009
The eye and visual system in pregnancy, what to expect? An in-depth review. Oman J Ophthalmol (2013) 1.12
Nonarteritic anterior ischemic optic neuropathy as the presenting manifestation of primary antiphospholipid syndrome. Indian J Ophthalmol (2014) 1.10
Pregnancy and the Eye. Turk J Ophthalmol (2015) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol (1999) 1.90
Ocular features associated with anticardiolipin antibodies: a descriptive study. Am J Ophthalmol (2001) 1.53
Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol (2003) 1.24
Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Eur J Clin Invest (2003) 0.96
Direct detection of Cardiobacterium hominis in serum from a patient with infective endocarditis by broad-range bacterial PCR. J Clin Microbiol (2006) 0.95
Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol (2006) 0.91
The antiphospholipid syndrome and infection. Curr Rheumatol Rep (2001) 0.87
Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion. Blood Coagul Fibrinolysis (2007) 0.87
Risk factors associated with HCV infection in semi-rural areas of central Greece. Eur J Intern Med (2007) 0.86
Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece. Eur J Intern Med (2008) 0.86
Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. J Autoimmun (2005) 0.84
Antiphospholipid (Hughes) syndrome. Autoimmunity (2004) 0.82
Anticardiolipin antibodies and occlusive vascular disease of the eye: prospective study. Doc Ophthalmol (1998) 0.81
The clinico-ophthalmological spectrum of antiphospholipid syndrome. Ocul Immunol Inflamm (1998) 0.79
Anticardiolipin antibodies and ocular disease. Ocul Immunol Inflamm (2005) 0.79
Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States. J Gen Intern Med (2007) 0.79
The antiphospholipid antibody syndrome. Curr Opin Ophthalmol (2000) 0.79
Unexplained choroidal embolisation: remember the antiphospholipid syndrome. Lancet (2006) 0.78
Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology (2008) 6.35
Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med (2011) 2.72
Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver Int (2008) 1.76
Volume flow and wall shear stress quantification in the human conjunctival capillaries and post-capillary venules in vivo. Biorheology (2007) 1.58
Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients. J Hepatol (2011) 1.56
Interobserver agreement in detecting spectral-domain optical coherence tomography features of diabetic macular edema. PLoS One (2015) 1.39
Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase. Int J Antimicrob Agents (2012) 1.16
Adipokines as mediators of endothelial function and atherosclerosis. Atherosclerosis (2013) 1.16
Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity. Autoimmun Rev (2011) 1.14
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun (2010) 1.13
Spontaneous spondylodiscitis: presentation, risk factors, diagnosis, management, and outcome. Int J Infect Dis (2008) 1.12
Blood velocity pulse quantification in the human conjunctival pre-capillary arterioles. Microvasc Res (2010) 1.09
Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics (2011) 1.08
Use of TNFα antagonists in refractory AIH: revealing the unforeseen. J Hepatol (2013) 1.07
Psychometric properties of the Greek version of the NEI-VFQ 25. BMC Ophthalmol (2008) 1.05
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta. Hepatology (2014) 1.04
The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis (2007) 1.02
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat? Liver Int (2011) 0.99
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int (2007) 0.96
Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int (2009) 0.96
Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach. Vision Res (2009) 0.95
Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification. BMC Infect Dis (2012) 0.95
Perimetric and retinal nerve fiber layer findings in patients with Parkinson's disease. BMC Ophthalmol (2012) 0.94
Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis (2004) 0.94
Resolution of macular edema in idiopathic juxtafoveal telangiectasis using PDT. Ophthalmic Surg Lasers Imaging (2009) 0.94
Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol (2007) 0.93
Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. World J Gastroenterol (2010) 0.92
Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis. Turk J Gastroenterol (2012) 0.92
IgA anti-b2GPI antibodies in patients with autoimmune liver diseases. J Clin Immunol (2008) 0.91
Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol (2006) 0.91
Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology (2007) 0.90
The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet (2005) 0.90
Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece. Eur J Gastroenterol Hepatol (2002) 0.89
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment. Antivir Ther (2011) 0.89
Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. Clin Exp Med (2013) 0.88
Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. Clin Diagn Lab Immunol (2005) 0.88
Unusual cardiovascular complications of brucellosis presenting in two men: two case reports and a review of the literature. J Med Case Rep (2011) 0.88
Safety and efficacy of transcatheter arterial chemoemboliazation in the real-life management of unresectable hepatocellular carcinoma. Hepat Mon (2013) 0.88
HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: results from five hemodialysis units in central Greece. J Clin Virol (2005) 0.87
Evaluation of MMP1 and MMP3 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma. Mol Vis (2009) 0.87
Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment. Liver Int (2011) 0.86
Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C. Am J Gastroenterol (2008) 0.86
Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clin Chim Acta (2007) 0.86
Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece. Eur J Intern Med (2008) 0.86
Molecular diagnostics of primary biliary cirrhosis. Expert Opin Med Diagn (2008) 0.86
HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome. Liver Int (2012) 0.85
Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology. PLoS One (2011) 0.85
Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? Dig Liver Dis (2010) 0.85
Sleep apnoea syndrome and early stage cirrhosis: a pilot study. Eur J Gastroenterol Hepatol (2006) 0.85
Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. J Autoimmun (2005) 0.84
Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat. World J Hepatol (2013) 0.84
Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease. Autoimmunity (2013) 0.84
Primary biliary cirrhosis and Henoch-Schonlein purpura: report of two cases and review of the literature. Liver Int (2007) 0.83
Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1. J Clin Immunol (2006) 0.82
IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases. Clin Chim Acta (2012) 0.82
Severe pharyngitis in stockbreeders: an unusual presentation of brucellosis. Occup Med (Lond) (2008) 0.82
Entecavir monotherapy for lamivudine-refractory chronic hepatitis B. Expert Rev Anti Infect Ther (2008) 0.82
Hepatitis B re-activation with rituximab therapy: treat the patient not the disease. Liver Int (2011) 0.82
Optic neuropathy secondary to Linezolid for multidrug-resistant mycobacterial spinal tuberculosis. Ocul Immunol Inflamm (2014) 0.82
Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis. J Hepatol (2006) 0.82
RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award Lecture. Retina (2016) 0.81
Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol (2003) 0.81
Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study. World J Gastroenterol (2005) 0.81
Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies. Eur J Gastroenterol Hepatol (2009) 0.81
European ST80 community-associated methicillin-resistant Staphylococcus aureus orbital cellulitis in a neonate. BMC Ophthalmol (2012) 0.80
Reactivation of resolved hepatitis B virus infection after immunosuppression: is it time to adopt pre-emptive therapy? Clin Res Hepatol Gastroenterol (2011) 0.80
Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen. Clin Chim Acta (2006) 0.80